• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Abbott Launches OTC Continuous Glucose Monitor, Lingo

by Jasmine Pennic 09/05/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Abbott Launches OTC Continuous Glucose Monitor, Lingo

What You Should Know: 

– Abbott, a global healthcare company, has announced the U.S. availability of Lingo, a continuous glucose monitoring (CGM) system designed for individuals who want to improve their overall health and wellness. 

– Lingo is the first CGM available without a prescription designed for individuals who want to improve their overall health and wellness, regardless of whether they have diabetes.

A Powerful Tool for Health Management

Lingo combines a biosensor worn on the back of the arm with a mobile app to provide real-time glucose data and personalized insights. By tracking glucose levels and understanding their relationship to food, exercise, and lifestyle factors, individuals can make informed decisions to improve their metabolic health.

Key Benefits of Lingo:

  • Improved Glucose Control: Lingo helps individuals better manage their glucose levels, reducing the risk of chronic health conditions.
  • Weight Management: By understanding how food and exercise affect glucose levels, individuals can make informed dietary choices to support weight management.
  • Better Sleep: A low-glycemic diet, supported by Lingo, can improve sleep quality and duration.
  • Enhanced Mood: Stabilizing glucose levels can positively impact mood and reduce symptoms of depression.

How Lingo Works

The Lingo system includes a biosensor that is worn on the back of the arm for up to 14 days. The biosensor continuously measures glucose levels and transmits data to the Lingo app on a smartphone. The app provides a personalized view of glucose data, including:

  • Glucose graph: A visual representation of glucose levels over time.
  • Lingo Count: A simple metric that summarizes glucose variability.
  • Food and Activity Logging: Tools to track meals and exercise.
  • Personalized Insights: Tailored recommendations based on individual glucose patterns.
  • Lingo Challenges: Interactive features to encourage healthy habits.

Lingo Options

Lingo is available in three options:

  • Learn: A two-week option for understanding glucose patterns.
  • Build: A four-week option for developing healthier habits.
  • Transform: A 12-week option for long-term glucose management.

Lingo offers a convenient and affordable way for individuals to improve their overall health and well-being. By providing valuable insights into glucose levels and offering personalized guidance, Lingo can empower people to make informed decisions and take control of their health.

“There is a great deal of interest in tracking biomarkers that provide insights into one’s health and wellness that were previously undetectable using the trackers available to consumers,” said Olivier Ropars, divisional vice president of Abbott’s Lingo business. “Glucose is a powerful signal of your body’s unique response to food and lifestyle. Abbott’s Lingo tracks your glucose 24/7, translating the data into insights and bridging the gap between traditional healthcare and preventative measures. Lingo empowers individuals to build new healthy habits and take control of their health and wellness.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Abbott, Continuous Glucose Monitoring (CGM), Diabetes Management, Diabetes Management Platform

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |